1J5 — Hyphens Pharma International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual balance sheet for Hyphens Pharma International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.5	19.5	36.5	24.2	24.4
Net Total Accounts Receivable
Net Total Receivables	23.7	28.7	31.1	40.4	44.7
Total Inventory
Prepaid Expenses
Total Current Assets	68.7	74.1	89.7	92.2	106
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.81	4.41	3.02	4.86	4.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	81.5	99.2	114	121	136
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.3	42.6	40.1	49.2	57.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	34.3	44.5	45.4	57.8	64.9
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	47.2	54.7	69	63	70.9
Total Liabilities & Shareholders' Equity	81.5	99.2	114	121	136
Total Common Shares Outstanding